Abstract
Analyses of data from the Women's Health Study suggest that the relative risks of hospitalization for PID were lower for women with tubal sterilizations and women whose partners had been sterilized (p<0.05), compared to sexually active non-contraceptors or women using oral or barrier methods. Further studies should be conducted to evaluate this non-contraceptive benefit of sterilization.
Resumé
Des analyses de résultats du Women's Health Study indiquent que les risques relatifs d'hospitalisation pour inflammation pelvienne sont plus faibles chez des femmes ayant subi une stérilisation tubaire et des femmes dont le partenaire a été stérilisé (p<0.05), que pour des femmes sexuellement actives et n'utilisant aucune méthode contraceptive, ou utilisant des contraceptifs oraux ou des barrières. D'autres études devront être effectuées afin d'évaluer les avantages non contraceptifs de la stérilisation.
Sumario
Análisis de datos del Estudio Salud de la Mujer, sugiere que los riesgos relativos de hospitalización por inflamación pelviana (PID) fueron más bajos para mujeres con esterilización tubaria y mujeres cuyos compañeros han sido esterilizados (p<0.05) comparados con mujeres sexualmente activas que no usaban anticonceptivos o mujeres usando la píldora o métodos de barrera. Estudios adicionales deberán ser hechos a fin de evaluar este beneficio no anticonceptivo de la esterilización.
Similar content being viewed by others
References
BurkmanR. T. and The Women's Health Study. (1981). Association between intrauterine device and pelvic inflammatory disease.Obstet. Gynecol.,57, 269–276
LeeN. C., RubinG. L., OryH. W. and BurkmanR. T. (1983). Type of intrauterine device and the risk of pelvic inflammatory disease.Obstet. Gynecol.,62, 1–6
StadlB. V. and SchlesselmanS. (1984). Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use.Obstet. Gynecol.,63, 171–178
KelaghanJ., RubinG. L., OryH. W. and LaydeP. M. (1982). Barrier method contraceptives and pelvic inflammatory disease.J. Am. Med. Assoc.,248, 184–187
RubinG. L., OryH. W. and LaydeP. M. (1982). Oral contraceptives and pelvic inflammatory disease.Am. J. Obstet. Gynecol.,144, 630–635
SchlesselmanJ. J. (1982).Case-Control Studies. Design, Conduct, Analysis, Oxford University Press, New York
WashingtonA. E., GoveS., SchachterJ. and SweetR. L. (1985). Oral contraceptives.Chlamydia trachomatis infection, and pelvic inflammatory disease.J. Am. Med. Assoc.,253, 2246–2250
TothA., LesserM. L. and LabriolaD. (1984). The development of infections of the genitourinary tract in the wives of infertile males and the possible role of spermatozoa in the development of salpingitis.Surg. Gynecol. Obstet.,159, 565–569
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edelman, D.A. Pelvic inflammatory disease and contraceptive practice. Adv Contracept 2, 141–144 (1986). https://doi.org/10.1007/BF01849223
Issue Date:
DOI: https://doi.org/10.1007/BF01849223